Adenoviral Vectors with E1A Regulated by Tumor-Specific Promoters Are Selectively Cytolytic for Breast Cancer and Melanoma

This publication has 9 references indexed in Scilit:

• Target Gene Therapy for α-Fetoprotein-Producing Hepatocellular Carcinoma by E1B55k-Attenuated Adenovirus
  Biochemical and Biophysical Research Communications, 2001
• Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene
  Cancer Gene Therapy, 2000
• Replication-selective adenoviruses as oncolytic agents
  Journal of Clinical Investigation, 2000
• Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo
  Gene Therapy, 1999
• Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells
  Cancer Gene Therapy, 1999
• A simplified system for generating recombinant adenoviruses
  Proceedings of the National Academy of Sciences, 1998
• The Murine L-plastin Gene Promoter: Identification and Comparison with the Human L-plastin Gene Promoter
  DNA and Cell Biology, 1997
• An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
  Proceedings of the National Academy of Sciences, 1994
• Characterization of an adenovirus type 5 mutant carrying embedded inverted terminal repeats
  Virology, 1986